rimantadine has been researched along with Cross Infection in 7 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Cross Infection: Any infection which a patient contracts in a health-care institution.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Annual influenza immunization should be offered to elderly patients, subjects with chronic disease, and those in long-term residential or nursing home care." | 2.41 | Nosocomial transmission of influenza. ( Carman, WF; Kerr, G; Stott, DJ, 2002) |
| "Annual influenza immunisation of high-risk persons and their contacts, including healthcare workers, is the primary means of preventing nosocomial influenza." | 2.41 | Influenza in the acute hospital setting. ( Farr, BM; Hall, KK; Hayden, FG; Salgado, CD, 2002) |
| "Along with influenza vaccines, the world is currently almost completely dependent on two licensed drugs for the treatment or prevention of seasonal (influenza A and B viruses) and pandemic influenza (influenza A viruses)." | 1.35 | Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. ( Barr, IG; Holien, JK; Hurt, AC; Parker, MW, 2009) |
"This report and other information on influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC at | 1.30 | Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). ( , 1999) | |
| "Current influenza vaccines are about 80 percent protective, but grossly underused." | 1.27 | Community-acquired lower respiratory tract infections. Prevention and cost-control strategies. ( La Force, FM, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hurt, AC | 1 |
| Holien, JK | 1 |
| Parker, MW | 1 |
| Barr, IG | 1 |
| Stott, DJ | 1 |
| Kerr, G | 1 |
| Carman, WF | 1 |
| Patriarca, PA | 1 |
| Kater, NA | 1 |
| Kendal, AP | 1 |
| Bregman, DJ | 1 |
| Smith, JD | 1 |
| Sikes, RK | 1 |
| Salgado, CD | 1 |
| Farr, BM | 1 |
| Hall, KK | 1 |
| Hayden, FG | 1 |
| La Force, FM | 1 |
2 reviews available for rimantadine and Cross Infection
| Article | Year |
|---|---|
Nosocomial transmission of influenza.
Topics: Aged; Amantadine; Antiviral Agents; Cross Infection; Health Personnel; Humans; Influenza Vaccines; I | 2002 |
Influenza in the acute hospital setting.
Topics: Acetamides; Amantadine; Antiviral Agents; Cross Infection; Disease Outbreaks; Guanidines; Hospitals; | 2002 |
1 trial available for rimantadine and Cross Infection
| Article | Year |
|---|---|
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes.
Topics: Adamantane; Cross Infection; Humans; Influenza A virus; Influenza, Human; Nursing Homes; Rimantadine | 1984 |
4 other studies available for rimantadine and Cross Infection
| Article | Year |
|---|---|
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
Topics: Cross Infection; Drug Resistance, Viral; Global Health; Humans; Influenza A virus; Influenza A Virus | 2009 |
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Breast Feeding; Child; Child, Preschool; Cont | 1997 |
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Cost of Illness; Cro | 1999 |
Community-acquired lower respiratory tract infections. Prevention and cost-control strategies.
Topics: Amantadine; Cost Control; Cross Infection; Humans; Influenza Vaccines; Influenza, Human; Pneumonia; | 1985 |